Liver Cancer Doctors Worldwide

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Prof. Sezer Sağlam specializes in liver cancer with over 27 years of medical oncology experience at Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University's renowned Medical Faculty
• Special focus on gastrointestinal oncology
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Professor Doctor Sefik Igdem specializes in Radiation Oncology at Gayrettepe Florence Nightingale Hospital, focusing on advanced treatments for liver cancer.

• Expert in conformal treatments for precise radiation therapy
• Uses Truebeam Stx and Halcyons technologies for targeted therapy
• Professor at T.R Demiroğlu Bilim University with extensive academic contributions
• Specializes in head and neck cancers alongside liver cancer treatments

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Specializes in targeted treatment and immunotherapy for liver cancer – combines precision medicine with advanced therapies at Liv Bona Dea Hospital Baku.

• Trained at prestigious institutions including Istanbul University and Cleveland Clinic
• Extensive research on cancer treatments with multiple published studies
• Focuses on individualized treatment plans including cytotoxic chemotherapy and hormonotherapy
• Skilled in palliative care for cancer patients

Dr. Almog Ben Yaacov is a senior surgical oncologist at Sheba Medical Center. He has performed over 200 HIPEC procedures for complex abdominal cancers. He focuses on treating gastric cancer, sarcoma, and colorectal malignancies. Dr. Ben Yaacov holds board certifications in both General Surgery and Surgical Oncology.

• Completed surgical oncology training at Memorial Sloan Kettering in New York.
• Uses NanoKnife and microwave liver ablation for targeted tumor treatment.
• Maintains ESSO certification for cytoreductive surgery and HIPEC.
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Serkan Keskin has performed over 1,100 procedures, utilizing advanced systemic therapies like immunotherapy. He is a Professor of Medical Oncology in Turkey.

• Holds 25 years of specialized experience in oncology
• Ranked first nationally on the medical oncology qualification exam in 2012
• Published 42 articles in international journals, contributing to the field
• Member of leading societies like ASCO and ESMO

Dr. Mustafa Solak completed fellowship training at Hacettepe University Cancer Institute, specializing in gastrointestinal cancers including liver cancer.

• Specialized at The University of Texas MD Anderson Cancer Center
• Handles complex cases of breast, lung, and gastrointestinal cancers
• Trained at Istanbul Sisli Etfal Training and Research Hospital

Over 2,500 radiotherapy sessions completed with MR-Linac – Assoc. Prof. Turkkan specializes in advanced radiation techniques at Hisar Hospital Intercontinental.

• Expert in stereotactic and MRI-guided radiotherapy for liver cancer
• Associate Professor with 27 published articles in oncology
• Member of European Society of Radiotherapy and Oncology (ESTRO)
• Trained at Maastricht University's MAASTRO Clinic in advanced techniques

Dr. Kivanc Derya Peker has performed over 200 liver surgeries with a focus on complex hepatobiliary cases at Hisar Hospital Intercontinental.

• Fellowship-trained in Hepatopancreatobiliary Surgery at Mayo Clinic (USA)
• Founder of the Hepatopancreatobiliary Surgery unit at Bakırköy Dr. Sadi Konuk Hospital
• Performed over 400 pancreatic and gastric cancer surgeries
• Specializes in liver cancer, pancreatic diseases, and complex biliary tract surgeries

Prof. Yildirim specializes in cancer immunotherapy and targeted therapies, with over 22 years at Anadolu Medical Center. She's a leading expert in hepatocellular carcinoma.

• Member of ESMO and ESO with 80+ international publications
• Focuses on cutting-edge treatments for liver tumors using newest protocols
• Professor at Haliç University with training in UK and Israel
• Expert in precision medicine approaches for gastrointestinal cancers